Haemonetics | HAE - Ebitda

سعر السهم
59.93
التغيير اليومي
0.31 0.52%
شهريا
7.15%
سنويا
-4.13%
Q2 التوقعات
58.65




Ebitda تغيير تاريخ
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
ICU Medical USD 98.19M 27.67M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Neogen USD 48.2M 546K 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Plus Therapeutics USD -4.4M 2.94M 2025-09
Quidel USD 153.3M 23.8M 2025-12
ResMed USD 547.48M 27.46M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Steris USD 389.7M 22.5M 2025-09
Stryker USD 1.67B 206M 2025-09
Surmodics USD 3.43M 1.9M 2025-06
Teleflex USD -328.81M 536.43M 2025-09
Terumo JPY 69.99B 3.22B 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
US Physical Therapy USD 24.75M 899K 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12